DM0000: The mark consists of the horizontally-situated literal element "QELBREE" with a diamond shape to the right of the last letter "E" of the literal element "QELBREE"; the literal element "VILOXAZINE" underneath "QELBREE"; the literal element "EXTENDED-RELEASE CAPSULES" underneath "VILOXAZINE"; and the literal element "100 MG 150 MG 200 MG" underneath "EXTENDED-RELEASE CAPSULES".
GS0051: Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine
PM0001: QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES ONE HUNDRED MILLIGRAM ONE HUNDRED FIFTY MILLIGRAM TWO HUNDRED MILLIGRAM; QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES ONE ZERO ZERO MILLIGRAM ONE FIVE ZERO MILLIGRAM TWO ZERO ZERO MILLIGRAM